Onyx Biotec Limited (NSE:ONYX)

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Sterile Water for Injections	320.05M	Log In	Log In
Sterile Water for Injections Growth	-18.33%	Log In	Log In
Dry Powder Injections	205.35M	Log In	Log In
Dry Powder Injections Growth	7696.17%	Log In	Log In
Dry Powder Syrup	12.09M	Log In	Log In
Dry Powder Syrup Growth	4011.56%	Log In	Log In

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
India	537.49M	Log In	Log In
India Growth	36.14%	Log In	Log In